-

DARK Daily: New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas--(BUSINESS WIRE)--There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

DARK Daily has recently published an all-new, comprehensive Special Report that brings together a literal who’s who of legal, regulatory, and other experts who serve the clinical lab industry. This comprehensive report provides laboratory professionals with an indispensable topic-by-topic explanation and understanding of relevant federal and state laws, legal and compliance issues, and more— all the essentials for risk management when it comes to developing a profitable and successful COVID-19 employee screening and testing program for their lab.

The Special Report puts together the vast expertise of the clinical laboratory profession’s most respected legal, regulatory, and compliance experts in one indispensable manual. Collected into one concise resource is the knowledge and advice that would take lab teams months to track down and identify.

Topics included in this Special Report include:

  • Ten QUICK-HIT Regulatory Essentials When Launching a COVID-19 Testing Program
  • Addressing COVID-19 Individual Test Eligibility Considerations
  • Understanding and Following Order Requirements for COVID-19 Testing
  • Privacy Considerations for COVID-19 Screening, Testing, and Contact Tracing
  • Contractual and Liability Issues in Employer COVID-19 Testing Arrangements
  • Infection Prevention and OSHA Compliance in the Time of COVID-19
  • Enlightening Case Studies from Northwell Health and UDoTest
  • Plus numerous helpful sample documents including Screening Questionnaires, Consent Forms, Orders for Testing, Quick-Start guide to CMS CLIA Certification, and more

The Report contains insights and information from the nation’s first-rank law attorneys, all with extensive and relevant healthcare experience:

  • McDonald Hopkins
  • Greenberg Traurig
  • Davis Wright Tremaine
  • Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
  • Foley & Lardner, and others

Lab professionals can leverage the informed intelligence this Special Report contains and for a modest investment, potentially boost their lab’s bottom line this year by thousands.

For more information and to download the Report, visit: https://www.darkdaily.com/how-to-develop-a-covid-19-employee-testing-program-what-clinical-laboratories-need-to-know

Contacts

Liz Carey
lcarey@darkreport.com

Industry:

DARK Daily

Release Summary
DARK Daily: New Special Report provides clinical labs legal, regulatory guidelines to develop profitable COVID-19 employee testing programs
Release Versions
English

Contacts

Liz Carey
lcarey@darkreport.com

More News From DARK Daily

LabX Media Group Acquires The Dark Intelligence Group Inc, including The Dark Report and the Executive War College

AUSTIN, Texas--(BUSINESS WIRE)--The Dark Intelligence Group (TDIG) announced today that it has sold all its information services assets to LabX Media Group of Midland, Ontario, Canada. This sale involves all TDIG products and services, such as The Dark Report intelligence service, DarkDaily ebriefings, webinars, reports, and events, including the Executive War College on Diagnostic, Laboratory, and Pathology Management, the largest global conference on laboratory management for senior laborator...

Operationalizing FDA LDT Compliance: Expert Panel Reveals Essential Strategies and Actions for Meeting the 1st Reporting Milestone

AUSTIN, Texas--(BUSINESS WIRE)--Many clinical laboratories are now under the gun to achieve Phase One compliance with the Food and Drug Administration’s (FDA) LDT rule before the May 2025 deadline. Labs performing LDTs must take immediate action to protect their most important LDTs that improve patient care while generating substantial reimbursement. This is a high stakes situation for labs offering LDTs because they have only five months to secure their most valuable LDTs. To help labs underst...

Experts to Identify Essential Steps & Pitfalls to Help Clinical Laboratories Meet the Deadline to Comply with the FDA’s Laboratory Developed Test (LDT) Rule

AUSTIN, Texas--(BUSINESS WIRE)--With the first important deadline for compliance with the Food and Drug Administration’s (FDA) LDT rule only eight months away, experts urge clinical laboratories performing LDTs to take immediate action. This is essential to protect their most important LDTs that improve patient care while generating substantial reimbursement. The FDA’s final rule on Laboratory Developed Tests (LDTs) ushers in a radical overhaul of the FDA’s longstanding policy of enforcement di...
Back to Newsroom